Skip to content
Contact Us
Institute@Precision

Insight for what’s next

The Institute@Precision was created to bring together the people driving discovery, development, and delivery, and to turn their collective experience into shared insight. It's a collaborative space for learning, connecting, and accelerating progress across the entire precision development and commercialization pathway.​

Explore insights Engage experts
By the numbers

Perspectives that span R&D and commercialization​

Access perspectives that are deeply rooted in real world experience, across the entire drug lifecycle, from early research through development, access and commercialization. 

25 +
years conducting oncology trials
700 +
clinical trials supported worldwide
150 +
PhDs, MDs
and PharmDs
425 +
launches and label expansions
Institute@Precision Series

One hot topic every quarter. Multiple expert perspectives.

Each Institute@Precision series puts a timely issue under the microscope. Through the eyes of experts from across the healthcare continuum, we explore the challenges and opportunities that determine how innovations reach patients. 

page-hero-placeholder
Asia-Pacific Opportunity and complexity are growing

APAC’s impact is no longer regional. It is redefining how innovative therapies
move from development to global markets. What does it take to turn APAC’s
emerging opportunities into strategic advantage?

radiopharm-topic-card
Radiopharmaceuticals Tuning out the noise

Radiopharmaceuticals are attracting unprecedented attention, investment and optimism. Our quarterly series cuts through the complexities, bringing together expert points of view on the research, regulatory, operational and commercial realities driving the narrative.  

adcs-topic-card
Antibody-Drug Conjugates Promises, pressure and progress.

ADCs have transformed oncology, but the road ahead is far from straightforward. Explore the perspectives, lessons and strategic considerations influencing the next era of ADC development. 

Subscribe today

Insights in your inbox

Institute@Precision works as an ever-evolving dialogue. Go deep into emerging topics, surface your own perspectives and help influence the crucial conversations happening across biopharma. 

 
Inside the institute

See what the experts see.

Moving from molecule to market with Precision

Institute@Precision draws on expertise from across Precision Medicine Group. Together our organizations span the spectrum from molecule to market, providing actionable answers to the most pressing questions in healthcare innovation, from multiple angles.  

precision-medicine-group
Precision Medicine Group Precision in every stage

Precision Medicine Group is a global team of 3,500 experts operating across two groups: Precision for Medicine and Precision AQ, supporting life science organizations from the lab to trials to launch and through product maturity.​

precision-for-medicine
Research & Development Next-gen clinical development​​​

Precision for Medicine helps sponsors navigate the complex development pathway through scientific expertise, clinical excellence and data-driven insights.  

precision_aq-logo-horizontal-2_color-RGB_reverse_R
Commercialization Opening up access

Precision AQ helps innovators translate evidence into action, combining strategy, insight and communications expertise to enable broader access to life-changing medicines.  

The experts’ view

Meet the people behind the progress

Continue the conversation alongside the experts. From development to commercialization, their perspectives are helping to shape the future for precision medicines. 

Contact Us